- Home
- PVLA vs EVT Comparison
PVLA vs EVT Comparison
Compare PVLA & EVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PVLA | EVT |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.1B |
| IPO Year | 2013 | 2003 |
Fundamental Metrics
Financial Performance| Metric | PVLA | EVT |
|---|---|---|
| Price | $151.21 | $28.16 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $171.87 | N/A |
| AVG Volume (30 Days) | ★ 160.3K | 80.7K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 52.62 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $42,810,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $104,350.18 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 65.28 | N/A |
| 52 Week Low | $56.55 | $23.00 |
| 52 Week High | $161.38 | $29.65 |
Technical Indicators
Market Signals| Indicator | PVLA | EVT |
|---|---|---|
| Relative Strength Index (RSI) | 50.36 | 41.30 |
| Support Level | $145.91 | $26.98 |
| Resistance Level | $151.18 | $29.25 |
| Average True Range (ATR) | 5.61 | 0.38 |
| MACD | -0.27 | -0.14 |
| Stochastic Oscillator | 51.04 | 31.98 |
Price Performance
Historical ComparisonAbout PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.
About EVT Eaton Vance Tax Advantaged Dividend Income Fund of Beneficial Interest
EATON VANCE TAX ADVANTAGED DIVIDEND INCOME FUND is a diversified, closed-end management investment company. Its objective is to provide a high level of after-tax total return consisting mainly of tax-advantaged dividend income and capital appreciation. The fund pursues its objective by investing in dividend-paying common and preferred stocks. Its portfolio of investments consists of electric utilities, energy equipment and services, food products, health care providers and services, internet software and services, and other areas.